QURE today
$24.05-$0.54 (-2.18%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourExpanding
1 hourStrong Bullish
15 minStrong Bullish
5 minStrong Bullish
Daily trend turns up above $26.68
Key levels
Resistance$28.71
Resistance$25.99
Support$23.89
Support$20.58
Latest news & SEC filings
SEC FilinguniQure N.V. filed an insider trading report (Form 4)
AnalystAnalysts adjust their views on uniQure N.V.
EarningsuniQure Posts Q3 2026 Results
EarningsuniQure holds Q3 2026 earnings call
EarningsuniQure posts smaller quarterly loss than expected, revenue falls short
All QURE news →About uniQure
uniQure is a gene therapy company developing one-time treatments for rare and severe diseases. Its clinical programs target a inherited neurodegenerative disorder, a form of epilepsy that does not respond to medication, a lysosomal storage condition, and a genetic form of ALS, plus earlier-stage research. The company also develops delivery and gene-silencing technologies and operates in the United States and Europe.
Based on the company's 10-K filed Mar 2, 2026.
Nasdaq · Healthcare
uniQure N.V. (QURE)
What Is the Price Target for QURE?
SEPT Low Target
$55.25
SEPT Mid Target
$65.00
SEPT High Target
$74.75
Analyst Consensus
$65.00
Is QURE a Buy or Sell Right Now?
Thesis
- •Revenue growing -40.6% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for QURE.
Start Free Trial →Is QURE Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, PEG, Analyst Consensus
Fair Value
$54.39
15
Moat Score
NONE
4/9
Piotroski Score
-0.9
Altman Z-Score
What Is Smart Money Doing with QURE?
Insider Signal
SELLING
0 buys / 15 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
ACCUMULATING
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Meek David D. | director | Sale | 9,080 | $193K | Nov 6, 2026 |
| Abi-Saab Walid | officer | Buy | 18,750 | - | Oct 30, 2026 |
| Kapusta Matthew C | director officer | Buy | 21,082 | $409K | Jul 2, 2026 |
| Kapusta Matthew C | director officer | Sale | 9,200 | $409K | Jul 2, 2026 |
| Kapusta Matthew C | director officer | Sale | 4,282 | $195K | Jul 2, 2026 |
| Kapusta Matthew C | director officer | Sale | 7,600 | $349K | Jul 2, 2026 |
| Kaye Jack | director | Buy | 4,107 | $152K | Jun 30, 2026 |
| Kaye Jack | director | Sale | 4,107 | $191K | Jun 30, 2026 |
| Kaye Jack | director | Buy | 17,060 | $344K | Jun 30, 2026 |
| Kaye Jack | director | Sale | 17,060 | $792K | Jun 30, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →QURE Growth Story
Revenue YoY
-40.6%
3yr Revenue CAGR
-46.7%
EPS Growth YoY
29.67%
FCF Growth YoY
4.1%
Revenue Trend
ACCELERATING
Dark Pool Trades for QURE
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for QURE, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:09 | $24.59 | 1,079,245 | $$26.5M | BUY |
| 21:00:08 | $24.59 | 1,793 | $$44K | BUY |
| 21:00:08 | $24.59 | 2,700 | $$66K | BUY |
| 20:59:19 | $24.64 | 1,900 | $$47K | MIDPOINT |
| 20:52:06 | $24.50 | 5,479 | $$134K | BUY |
5 dark pool trades shown · $$26.8M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for QURE
PREVIEWSEPT Investing provides real-time options flow tracking for QURE, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $25 | Nov 20 | 9 | $$805 | 7 | SWEEP |
| CALL | $25 | Nov 20 | 9 | $$115 | 1 | SWEEP |
| CALL | $25 | Nov 20 | 9 | $$115 | 1 | SWEEP |
| CALL | $25 | Nov 20 | 9 | $$115 | 1 | SWEEP |
| CALL | $25 | Nov 20 | 9 | $$115 | 1 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for uniQure N.V. (QURE) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →QURE — frequently asked questions
What is QURE stock price today?
uniQure N.V. (QURE) is at $24.05, down 2.18% (-$0.54) at the Nov 12, 2026 close.
Why is QURE stock moving today?
Latest QURE news — Nov 10, 2026: uniQure N.V. filed an insider trading report (Form 4) · Nov 7, 2026: Analysts adjust their views on uniQure N.V.
What is the QURE price target?
The average analyst price target for QURE is $65.00, ranging from $28 to $80, based on 9 analysts. Latest: Barclays downgrade on Oct 5, 2026.
What do analysts rate QURE?
Analyst ratings for QURE: 2 Buy, 13 Hold, 0 Sell — consensus Hold.
Did QURE beat earnings?
QURE last reported on Jul 29, 2026: EPS -$1.22 vs -$0.82 expected — a miss of 48.4%.
Does QURE pay a dividend?
QURE does not currently pay a dividend.
What are QURE support and resistance levels?
Support: $23.89, $20.58, $17.00. Resistance: $25.99, $28.71, $31.00.
What are insiders doing with QURE?
Insider activity: SELLING, 0 buys and 15 sells in the last 90 days.
What is the latest news on QURE?
Nov 10, 2026: uniQure N.V. filed an insider trading report (Form 4) · Nov 7, 2026: Analysts adjust their views on uniQure N.V. · Nov 4, 2026: uniQure Posts Q3 2026 Results